ELAVL1 and breast carcinoma: Taken together, our results suggest that eltrombopag affected the migration and invasion of breast cancer cells by targeting the HuR protein and inhibiting its binding to the mRNA of tumor metastasis-related genes, thereby inhibiting the expressions of related genes.